| Glycoprotein-D–adjuvant vaccine to prevent genital herpes LR Stanberry, SL Spruance, AL Cunningham, DI Bernstein, A Mindel, ... New England Journal of Medicine 347 (21), 1652-1661, 2002 | 988 | 2002 |
| Vaccine hesitancy and healthcare providers P Paterson, F Meurice, LR Stanberry, S Glismann, SL Rosenthal, ... Vaccine 34 (52), 6700-6706, 2016 | 836 | 2016 |
| VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection R Rupp, SL Rosenthal, LR Stanberry International journal of nanomedicine 2 (4), 561-566, 2007 | 373 | 2007 |
| Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2. 4xM2e) in healthy adults CB Turley, RE Rupp, C Johnson, DN Taylor, J Wolfson, L Tussey, ... Vaccine 29 (32), 5145-5152, 2011 | 321 | 2011 |
| Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection N Bourne, LR Stanberry, ER Kern, G Holan, B Matthews, DI Bernstein Antimicrobial agents and chemotherapy 44 (9), 2471-2474, 2000 | 276 | 2000 |
| Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease LR Stanberry, ER Kern, JT Richards, TM Abbott, JC Overall Jr Journal of Infectious Diseases 146 (3), 397-404, 1982 | 274 | 1982 |
| Prospects for control of herpes simplex virus disease through immunization LR Stanberry, AL Cunningham, A Mindel, LL Scott, SL Spruance, FY Aoki, ... Clinical Infectious Diseases 30 (3), 549-566, 2000 | 253 | 2000 |
| Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2 KZ Bourne, N Bourne, SF Reising, LR Stanberry Antiviral research 42 (3), 219-226, 1999 | 236 | 1999 |
| Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial DI Bernstein, FM Munoz, ST Callahan, R Rupp, SH Wootton, KM Edwards, ... Vaccine 34 (3), 313-319, 2016 | 224 | 2016 |
| Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes LR Stanberry, DI Bernstein, RL Burke, C Pachl, MG Myers Journal of Infectious Diseases 155 (5), 914-920, 1987 | 221 | 1987 |
| Vaccination of special populations: Protecting the vulnerable M Doherty, R Schmidt-Ott, JI Santos, LR Stanberry, AM Hofstetter, ... Vaccine 34 (52), 6681-6690, 2016 | 200 | 2016 |
| DNA immunization against experimental genital herpes simplex virus infection N Bourne, LR Stanberry, DI Bernstein, D Lew Journal of Infectious Diseases 173 (4), 800-807, 1996 | 195 | 1996 |
| A pooled analysis of the effect of condoms in preventing HSV-2 acquisition ET Martin, E Krantz, SL Gottlieb, AS Magaret, A Langenberg, L Stanberry, ... Archives of internal medicine 169 (13), 1233-1240, 2009 | 182 | 2009 |
| Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of … P Vandepapeliere, R Barrasso, CJLM Meijer, JMM Walboomers, ... The Journal of infectious diseases 192 (12), 2099-2107, 2005 | 158 | 2005 |
| Herpes simplex virus vaccines DI Bernstein, LR Stanberry Vaccine 17 (13-14), 1681-1689, 1999 | 152 | 1999 |
| Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs N Bourne, FJ Bravo, M Francotte, DI Bernstein, MG Myers, M Slaoui, ... The Journal of infectious diseases 187 (4), 542-549, 2003 | 151 | 2003 |
| Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. LR Stanberry Herpes: the journal of the IHMF 11, 161A-169A, 2004 | 150 | 2004 |
| Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes DI Bernstein, LR Stanberry, S Sacks, NK Ayisi, YH Gong, J Ireland, ... Antimicrobial agents and chemotherapy 47 (12), 3784-3788, 2003 | 150 | 2003 |
| Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection RB Pyles, D Higgins, C Chalk, A Zalar, J Eiden, C Brown, G Van Nest, ... Journal of Virology 76 (22), 11387-11396, 2002 | 145 | 2002 |
| New developments in the epidemiology, natural history and management of genital herpes L Stanberry, A Cunningham, G Mertz, A Mindel, B Peters, M Reitano, ... Antiviral research 42 (1), 1-14, 1999 | 136 | 1999 |
